Report Feature
In this market, instruments is the largest product of sequencing pipe, whereas biomarker & cancer is the largest application. Growth in various segments of the sequencing market are given below:
The study includes trends and forecast for the global sequencing market by product, technology, platform, application, end user, and region as follows:
- Consumables
- Instruments
- Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by ligation
- Pyrosequencing
- Single-molecule Real-time Sequencing
- Chain Termination Technology
- Nanopore Sequencing
By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:
- Sanger
- Next Generation Sequencing
- qPCR
- Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biomarker & Cancer
- Diagnostics
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Lucintel forecasts that instruments will remain the fastest growing product segment over the forecast period due to recent advancements in instruments for DNA sequencing.
Within this market, biomarker and cancer will remain the largest application segment over the forecast period due to increasing prevalance of cancer worldwide.
|
Features of the Global Sequencing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global sequencing market by product (consumables, instruments, and services ), technology (sequencing by synthesis, Ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination technology, and nanopore sequencing), platform (sanger, next generation sequencing, qPCR, and others), application (biomarker & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others), end user (academic & government research institutes, pharmaceutical companies, biotechnology companies, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global sequencing market? Q.5 What are the business risks and threats to the global sequencing market? Q.6 What are the emerging trends in the sequencing market and the reasons behind them? Q.7 What are some changing demands of customers in the sequencing market? Q.8 What are the new developments in the sequencing market? Which companies are leading these developments? Q.9 Who are the major players in the sequencing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in the sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global sequencing market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Consumables, Instruments, and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-Molecule Real-Time Sequencing, Chain Termination Technology, and Nanopore Sequencing), Platform (Sanger, Next Generation Sequencing, qPCR, and Others), Application (Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, And Others), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, and Germany), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.